Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes
0
Authors
Bo Åhrén
4 more
Bo Åhrén
•
Ramón Gomis
2 more
•
Anja Schweizer
Published
December 1, 2004
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Diabetes Care
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Endocrinology
Show all topics
DOI
10.2337/diacare.27.12.2874
